University of Parma
University of Parma
Università degli Studi di Parma (UNIPR) is a medium-size University, with more than 27,000 students and a total of more than 1000 research and teaching staff. UNIPR is highly committed in both teaching and research, offering a variety of educational curricula and programs, from bachelor to PhD courses. In this context, many multilateral cooperation agreements with higher education institutions in Europe have been set up thus promoting student and teaching staff mobility throughout Europe.
Dipartimento Farmaceutico (DIPFARM) is a research-based department of the Faculty of Pharmacy of UNIPR, employing 30 full time research/teaching staff, from full professors to assistant professors and lecturers. DIPFAR is characterized by an intense scientific activity in the field of pharmaceutical technology, organic chemistry, and medicinal chemistry (www.unipr.it/arpa/dipfarm.). The DIPFARM holds the Ph.D. Course in Biopharmaceutics-Pharmacokinetics and is the associate centre for the Ph.D. Course in Pharmaceutical Chemistry and Technology. DIPFARM hosts the Master Course in Pharmaceutical Technology and Regulatory Affairs and is part of the GALENOS European network. Since June 2006, the Faculty of Pharmacy of UNIPR is part of the ULLA consortium for Advanced Pharmaceutical Education and Research.
Key staff involved:
Full professor of medicinal chemistry. His scientific interests cover the development and application of molecular modelling techniques, homology modelling and molecular dynamics in particular, to the study of membrane and nuclear receptors. Gabriele Costantino has been awarded with the ‘Farmindustria/Italian Chemical Society’ prize for the best young researcher in medicinal chemistry (2003) and has been visiting professor at the Goethe University (Frankfurt am Main) under the Friederich Merz fellowship. He is member of the Information and Communication Committee of the European Federation for Medicinal Chemistry and he is Secretary of the Scientific Committee of the European School of Medicinal Chemistry (ESMEC-Urbino).
Full professor of medicinal chemistry. His scientific interest are the study of structure-activity relationships and the application of QSAR and molecular modeling techniques to the design of compounds acting as histamine H3 antagonists; melatonin MT1 and MT2 ligands, nuclear receptor ligands, compounds acting on the cannabinoid pathway; study of the relationships between drug lipophilicity and their pharmacokinetic and metabolic behaviour. Marco Mor is President of the Council for the Degree in "Chemistry and Technology of Drugs (C.T.F)" at the University of Parma since 2005. He is member of the Board of Professors of the PhD program in Chemistry and Technology and Drugs (University of Pavia / Parma).